PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424969
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1424969
Cell Penetrating Peptide Market size was valued at USD 1,577.23 Million in 2023, expanding at a CAGR of 10.2% from 2024 to 2032.
Cell-penetrating peptides (CPPs) are a broad class of short peptides that can penetrate cell membranes without compromising their structural or functional integrity. They have been extensively studied for their potential to transport therapeutics, bioactive molecules, and theragnostic cargoes inside of cells. Since these characteristics make therapeutically important macromolecules less permeable via biological membranes, they are especially desired.
Cell Penetrating Peptide Market- Market Dynamics
Growing demand from pharmaceutical & biotechnology companies drives market growth
As active CPP research and development organizations, pharmaceutical and biotechnology businesses as well as university research institutions are involved in the market. For instance, a better gene editing method created by the University of Pennsylvania's Perelman School of Medicine may fuel the next generation of gene and cell treatments, according to a Penn Medicine paper. The CRISPR gene editing method, which is based on special cell-penetrating peptides, offers potential advantages over current methods for altering biological genomes. Thereby, driving the market growth over the forecast period.
Cell Penetrating Peptide Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.2% over the forecast period (2024-2032)
Based on Type segmentation, Synthetic CPPs were predicted to show maximum market share in the year 2023
Based on application segmentation, Drug Delivery was the leading type in 2023
Based on End-User segmentation, Pharmaceutical and Biotechnology Companies were the leading type in 2023
Based on region, North America was the leading revenue generator in 2023
The Global Cell Penetrating Peptide Market is segmented based on Type, Application, End-User, and Region.
The market is divided into three categories based on Type: Synthetic CPPs, Protein-derived CPPs and Chimeric CPPs. The market is predominantly dominated by synthetic CPPs. Certain synthetic CPPs have been specifically engineered to possess multiple functionalities, enabling the concurrent administration of various payloads or the integration of therapeutic and diagnostic capabilities.
The market is divided into five categories based on application: Drug Delivery, Gene Delivery, Diagnostics, Molecular Imaging and Others. The market is primarily dominated by the Drug Delivery segment. Cell-penetrating peptides (CPPs) have attracted considerable attention in the drug delivery field because of their exceptional capability to enable the intracellular transportation of diverse therapeutic agents.
The market is divided into four categories based on End-user: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Hospitals and Clinics and Others. The market is predominantly controlled by Pharmaceutical and Biotechnology Companies. CPPs are employed in functional genomics research, providing means to manipulate gene expression and investigate cellular functions.
Cell Penetrating Peptide Market- Geographical Insights
Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is projected to be dominated by North America, primarily due to the increasing prevalence of diseases such as chronic and infectious diseases. The demand for innovative therapeutic approaches, including CPP-based solutions for drug delivery, is driven by the rising incidence and prevalence of these conditions. Chronic diseases, which are generally incurable and ongoing, affect approximately 133 million Americans, accounting for more than 40% of the country's total population. By 2020, this number is projected to reach an estimated 157 million, with 81 million individuals having multiple conditions, as reported by the National Health Council. Europe holds the second largest region for market growth, mainly due to the rising healthcare expenditure.
The market for cell penetrating peptides (CPPs) is witnessing significant growth due to the increasing demand in basic research to understand cellular processes and their role as tools for intracellular delivery in studies related to gene therapy, cancer, and neuroscience. The field of nanotechnology, gene editing, and other biotechnologies is also advancing, which may introduce new competitors or complementary technologies in the market. CPPs have garnered considerable attention in various fields, particularly drug delivery, due to their potential for facilitating the intracellular delivery of therapeutic molecules. Therefore, when analyzing the market for cell-penetrating peptides, it is crucial to consider competition analysis and demand in the context of their applications.
In July 2023, the U.S. FDA accepted Revance Therapeutics, Inc.'s additional biologic license application for DAXXIFY, which is intended to treat adult cervical dystonia.
GLOBAL CELL PENETRATING PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Pepscan
Creative Peptides
Cupidpeptides
AltaBioscience Ltd
AnaSpec
Peptomyc
BioAlps
Sarepta Therapeutics, Inc.
REVANCE THERAPEUTICS
PolyPeptide Group
Bachem
Others